Management of This Complex Case: Decompensated Valvular Heart Disease with Multi-Organ Involvement

Step 1: Interpreting the Clinical Picture

ABG Analysis

• pH 7.20 - acidaemic
• pCO2 34 mmHg - low (but not low enough for respiratory compensation)
• HCO3 16.5 mEq/L - low
• Anion Gap = Na - (Cl + HCO3) = stated as 14 (elevated, normal ~8-12)

• Expected pCO2 for compensation = 1.5 × HCO3 + 8 ± 2 = 1.5 × 16.5 + 8 = 32.75 ± 2 → actual pCO2 is 34, which is at the upper limit of adequate compensation. There may be a co-existing early respiratory acidosis (the SpO2 of 85% and bilateral pleural effusions are contributing).

The Elevated SGOT/SGPT

Step 2: Immediate Priorities (First 30-60 Minutes)

A. Oxygen and Airway

B. IV Access and Monitoring

• Two large-bore IV lines
• Continuous ECG monitoring (patient on digoxin - risk of toxicity)
• Urinary catheter for strict hourly output monitoring
• Pulse oximetry, NIBP every 15 minutes

Step 3: Drug Review and Adjustments

Current Medications - Critical Review:

Step 4: Diuresis Strategy

• Give IV furosemide at 2.5× the total oral daily dose
• Since she is on 20 mg oral, start with IV furosemide 40-80 mg as bolus or continuous infusion
• Target urine output ≥ 100-150 mL/hour initially
• Monitor electrolytes (Na, K, Cl) every 6-8 hours
• If diuresis is inadequate, consider torsemide (better oral bioavailability than furosemide in HF due to gut oedema) or add IV metolazone for synergistic effect (sequential nephron blockade)

Step 5: Managing the Metabolic Acidosis

1. Improve cardiac output (diuresis + vasodilators if not hypotensive)
2. Correct hypoxia (O2/NIV as above)
3. Sodium bicarbonate is generally NOT recommended for lactic acidosis unless pH < 7.1 with haemodynamic instability - it does not improve outcomes and may worsen intracellular acidosis. With pH 7.20, monitor closely but do not reflexively give bicarb.
4. If pH drops below 7.1 or patient deteriorates haemodynamically, cautious NaHCO3 may be considered

Step 6: The Pleural Effusions

• If effusions are very large and causing severe dyspnoea that does not respond to diuretics within 24-48 hours
• If there is suspicion of exudative aetiology (fever, unilateral, bloody - none here currently)
• If SpO2 remains critically low despite O2 therapy and NIV

Step 7: Addressing Congestive Hepatopathy (Elevated SGOT/SGPT)

• Avoid hepatotoxic drugs (NSAIDs, unnecessary statins at high doses)
• The ecosprin 75 mg is safe to continue
• Reassess liver enzymes after 48 hours of cardiac treatment

Step 8: Investigations to Order and Interpret

Step 9: Vasodilator Therapy (if not hypotensive)

• IV nitroglycerine (GTN): Reduces preload and afterload, relieves pulmonary congestion. Start at 5-10 mcg/min, titrate upward. Particularly useful in the first 24-48 hours alongside diuretics.
• Avoid if SBP < 90 mmHg

Step 10: Monitoring Targets

Summary Management Algorithm

ACUTE DECOMPENSATED HEART FAILURE + HAGMA + SpO2 85%
         ↓
1. O2 therapy → NIV (BiPAP) if needed
2. IV furosemide 40-80 mg → titrate to UO
3. HOLD metoprolol; CHECK digoxin level; ADJUST doses
4. IV GTN if SBP > 100
5. Strict I/O monitoring, daily weights
6. ABG repeat in 2-4 hours
7. Do NOT give bicarb unless pH < 7.10
8. Echo + ECG
9. Treat congestive hepatopathy by treating the heart
10. Reassess for thoracocentesis at 24-48 hrs if O2 still poor

Comprehensive Case Analysis and Management

Patient Summary

STEP 1: ABG Interpretation (Winter's Formula)

Expected pCO2 = (1.5 × HCO3) + 8 ± 2 = (1.5 × 16.5) + 8 ± 2 = 24.75 + 8 ± 2 = 30.75 - 34.75 mmHg

STEP 2: Diagnosis

1. Type A lactic acidosis (HAGMA from hypoperfusion + hypoxia)
2. Congestive hepatopathy (elevated SGOT/SGPT from elevated CVP)
3. Bilateral transudative pleural effusions
4. Bilateral lower limb oedema
5. SpO2 85% - severe hypoxaemia

STEP 3: Immediate Emergency Stabilisation

A. Oxygen - First Priority

• Start high-flow O2 via face mask (10-15 L/min, non-rebreather) targeting SpO2 ≥ 94%
• If no improvement within 15-20 min, escalate to Non-Invasive Ventilation - BiPAP (preferred over CPAP in HF with hypercapnic tendency; improves both oxygenation and offloads respiratory muscles)
  • Settings: IPAP 12-16 cmH2O, EPAP 5-8 cmH2O, FiO2 titrated to SpO2
• Prepare for endotracheal intubation only if:
  • NIV fails after 30-60 min
  • GCS deteriorates
  • Respiratory fatigue with rising pCO2 or haemodynamic collapse

B. Positioning and Monitoring

• Sit patient upright (45-60°) - reduces preload and improves diaphragmatic excursion
• Continuous ECG monitoring (patient on digoxin - arrhythmia risk)
• Pulse oximetry continuous
• NIBP every 15 minutes
• Urinary catheter for strict hourly urine output (UO) measurement

STEP 4: IV Access and Fluid Strategy

• Two large-bore IV cannulas
• Do NOT give IV fluids - this patient is fluid overloaded; diuresis is the goal
• Blood drawn: serum electrolytes (K+, Na+, Mg2+), serum digoxin level, lactate, RFT, LFTs, CBC, PT/INR, BNP/NT-proBNP, ECG

STEP 5: Diuretic Strategy - Core of Management

• She is on oral furosemide 20 mg OD
• Switch to IV furosemide 40-80 mg (at least 2-2.5× her oral dose) as an IV bolus
• If UO < 100 mL/hr after 1-2 hours, increase dose or switch to continuous IV infusion (5-10 mg/hr)
• The DOSE trial (referenced in Braunwald's) showed no significant difference between IV bolus and continuous infusion - use whichever approach achieves reliable diuresis
• Target UO: 100-150 mL/hr during active diuresis phase; aim to reduce weight 0.5-1.0 kg/day

• Add oral metolazone 2.5-5 mg 30 min before loop diuretic (synergistic: blocks distal tubule while furosemide blocks loop)
• Monitor closely for hypokalaemia, hyponatraemia, hypotension

STEP 6: Current Medication Review - Critical Adjustments

STEP 7: Vasodilator Therapy

• IV Glyceryl Trinitrate (GTN/Nitroglycerin): Start at 5-10 mcg/min, titrate up every 5-10 minutes to max 200 mcg/min
  • Reduces preload (venodilation) and at higher doses reduces afterload
  • Relieves pulmonary oedema component rapidly
  • Particularly effective when combined with IV diuresis
• Stop if SBP falls below 90 mmHg

STEP 8: Managing the Metabolic Acidosis (HAGMA)

1. Correct hypoxia (O2/NIV as above)
2. Improve cardiac output (diuresis + vasodilators)
3. Restore perfusion

• pH < 7.10 AND haemodynamic instability (not the case here yet)
• Even then: 1-2 mEq/kg IV over 30-60 min, recheck ABG
• Caution: NaHCO3 can cause paradoxical intracellular acidosis, hypernatraemia, volume overload

STEP 9: Congestive Hepatopathy (Elevated SGOT/SGPT)

• No specific hepatic treatment needed
• Avoid hepatotoxic drugs
• Do NOT use NSAIDs (worsen renal function, reduce diuretic efficacy)
• Check bilirubin, PT/INR (assesses hepatic synthetic function)
• Liver enzymes will normalise as cardiac function improves
• If transaminases are >10× ULN, consider ischemic hepatitis - requires urgent haemodynamic stabilisation

STEP 10: Bilateral Pleural Effusions

• SpO2 remains critically low (< 88%) despite O2 and NIV
• Very large effusions (>50% hemithorax) causing respiratory compromise
• Clinical suspicion of exudate (fever, unilateral effusion, malignancy)
• No improvement after 24-48 hours of aggressive diuresis

STEP 11: Investigations Checklist

STEP 12: Monitoring Targets During Admission

STEP 13: Ward vs ICU Decision

• SpO2 85% (potentially requiring NIV or intubation)
• pH 7.20 (severe acidosis)
• Digoxin toxicity risk with arrhythmia potential
• Age 78 + multi-organ involvement (cardiac, respiratory, hepatic)
• Needs continuous ECG monitoring and hourly UO assessment

Management Summary Flowchart

SpO2 85% + HAGMA + Bilateral Pleural Effusion + Decompensated VHD
                          ↓
     ┌──────────────────────────────────────┐
     │  IMMEDIATE (0-30 min)               │
     │  • High-flow O2 → BiPAP if needed   │
     │  • IV access, monitoring, catheter  │
     │  • HOLD metoprolol, HOLD digoxin    │
     │  • STAT: digoxin level, lactate, K+ │
     │  • ECG                              │
     └──────────────────────────────────────┘
                          ↓
     ┌──────────────────────────────────────┐
     │  FIRST HOUR                         │
     │  • IV furosemide 40-80 mg           │
     │  • IV GTN if SBP >100               │
     │  • Correct K+ if hypokalaemic       │
     │  • DO NOT give NaHCO3 unless pH<7.1 │
     └──────────────────────────────────────┘
                          ↓
     ┌──────────────────────────────────────┐
     │  2-4 HOURS: Reassess                │
     │  • Repeat ABG                       │
     │  • UO response to diuresis?         │
     │  • If diuretic resistant → add      │
     │    metolazone or escalate to        │
     │    continuous infusion              │
     │  • Echo: valvular severity, EF      │
     └──────────────────────────────────────┘
                          ↓
     ┌──────────────────────────────────────┐
     │  24-48 HOURS                        │
     │  • If effusions persist and O2      │
     │    still poor → thoracocentesis     │
     │  • Liver enzymes improving?         │
     │  • Titrate digoxin to safe level    │
     │  • Consider restarting beta-blocker │
     │    at lower dose once stable        │
     └──────────────────────────────────────┘

1. Digoxin toxicity - the combination of spironolactone (raises digoxin levels per Braunwald's), age 78, possible renal impairment, and metabolic acidosis (increases myocardial sensitivity) makes this the single most urgent drug concern. An ECG with bidirectional VT or high-degree AV block would require Digibind (antidigoxin Fab fragments) immediately.
2. Cardiorenal syndrome - aggressive diuresis may worsen renal function; acceptable up to creatinine rise of 0.3 mg/dL; beyond that, reassess dosing.
3. Respiratory failure - pH 7.20 with SpO2 85% in an elderly patient with limited reserve; early NIV is far preferable to crash intubation.
4. Congestive hepatopathy - do not mistake this for primary liver disease; treat the heart and the liver enzymes will follow. Per Sleisenger and Fordtran's Gastrointestinal and Liver Disease: "Therapy is generally directed at improving cardiac disease."